Soleno Therapeutics (SLNO) Debt to Equity (2012 - 2026)
Soleno Therapeutics (SLNO) debt to equity from Dec 31, 2012 to Mar 31, 2026. The current Soleno Therapeutics (SLNO) debt to equity is 10.06%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Soleno Therapeutics (SLNO)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 11.08% | -45.51% |
| 2024 | 20.33% | N/A |
| 2023 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | -40.91% | N/A |
| 2012 | 0.00% | N/A |
Comparison Soleno Therapeutics (SLNO) debt to equity with competitors
Soleno Therapeutics (SLNO) debt to equity is 10.06%.